STOCK TITAN

AMREP CORP. (AXR) CFO sells 4,000 shares at $23.49 in open-market trade

(Neutral)
(Negative)
Form Type
4

Rhea-AI Filing Summary

AMREP CORP. CFO and VP Adrienne Uleau sold 4,000 shares of Common Stock on 2026-07-30 at $23.49 per share in an open-market or private transaction. After this sale, she directly holds 6,574 shares. The transaction was not made under a Rule 10b5-1 trading plan.

Positive

  • None.

Negative

  • None.
Insider Uleau Adrienne
Role CFO and VP
Sold 4,000 shs ($94K)
Type Security Shares Price Value
Sale Common Stock 4,000 $23.49 $94K
Holdings After Transaction: Common Stock — 6,574 shares (Direct)
Shares sold 4,000 shares Common Stock sale on 2026-07-30 by CFO and VP Adrienne Uleau
Sale price $23.49 per share Price for 4,000 Common Stock shares sold on 2026-07-30
Shares held after sale 6,574 shares Direct Common Stock ownership of Adrienne Uleau following the reported sale
Rule 10b5-1 regulatory
"The sale was reported as not made under a Rule 10b5-1 plan"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
open market or private transaction financial
"Transaction code description states a sale in open market or private transaction"
direct ownership financial
"Ownership type is shown as direct ownership of the Common Stock"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did AMREP CORP. (AXR) disclose in this Form 4?

AMREP CORP. reported that CFO and VP Adrienne Uleau sold 4,000 shares of Common Stock on 2026-07-30 at $23.49 per share. The transaction was a sale in an open-market or private trade and reduced her direct holdings to 6,574 shares.

At what price and on what date did AXR's CFO sell AMREP CORP. shares?

CFO and VP Adrienne Uleau sold 4,000 Common Stock shares at $23.49 per share on 2026-07-30. The Form 4 describes this as a sale in an open-market or private transaction, reflecting a routine insider share disposition.

How many AMREP CORP. (AXR) shares does the CFO own after the reported sale?

Following the reported transaction, CFO and VP Adrienne Uleau directly owns 6,574 shares of AMREP CORP. Common Stock. This figure represents her direct holdings immediately after selling 4,000 shares in the open-market or private transaction disclosed in the Form 4.

Was the AMREP CORP. (AXR) CFO’s stock sale made under a Rule 10b5-1 plan?

No. The Form 4 indicates the Rule 10b5-1 checkbox was not selected, meaning the 4,000-share sale at $23.49 per share was not executed under a pre-arranged Rule 10b5-1 trading plan, but instead reported as a standard open-market or private transaction.

What type of transaction and ownership structure did AXR report for this insider trade?

The filing classifies the event as a sale of Common Stock in an open-market or private transaction. Ownership is reported as direct, with Adrienne Uleau holding the shares directly rather than through an intermediate entity, and 6,574 shares remaining after the sale.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Uleau Adrienne

(Last)(First)(Middle)
C/O AMREP CORPORATION
850 WEST CHESTER PIKE, SUITE 205

(Street)
HAVERTOWN PENNSYLVANIA 19083

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
AMREP CORP. [ AXR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CFO and VP
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/30/2026S4,000D$23.496,574D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
/s/ Adrienne M. Uleau07/30/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)